ZIMBABWE is currently experiencing a shortage in Rifabutin 150 mg tablets used in the treatment of drug sensitive Tuberculosis (DS-TB) among TB/HIV co-infected patients on second line treatment antiretroviral therapy (ART). By Michael Gwarisa In a communique written to all provincial hospitals, Permanent Secretary in the ministry of health and child care (MoHCC), Dr Jasper Chimedza said based on the current stock levels, the country would be stocked out by end of November 2020. The country is currently faced with shortages of Rifubutin 150mg tablets. The shortages are associated with…
Read MoreZimbabwe Hit By Shortage Of Drug Sensitive TB Tablets
